chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Employee received influenza vaccination on 10/22/07 at approx. 9:30 am and at approx. 6:15 pm the employee started to not feel well, dizziness, warm and developed a headache, Leg/feet cramps bilateral lasting a few minutes two times that evening(per employee toes curled), approx 10:00 pm employee states fever of 103 F.  Employee went to sleep, woke up aprox 1:00 am soaking wet, no fever. Headache remained.  Employee called department manager next am to call in sick for work, employee still had headache, planned on coming in later in afternoon.  Dept Mgr called this nurse and reported incident. This nurse called employee, employee stated "I'm doing better now"Headache remained, no fever, no dizziness, no return of leg/toe cramps.  Employee instructed if symptoms persist or return of fever, or new symtoms to call this nurse or ER as needed. Emp. reported to work 10/23 at 1:00 pm with mild headache, no other symptoms.  Aprox. 8:15 pm on 10/23 employee stated "I felt back to normal".  10/24 Emp. reported no further problems.
This spontaneous report received from a physician via company representative refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with GARDASIL 9 intramuscular injection (dose, frequency, lot number and expiry date were not reported). The physician reported that the patient had been experiencing raw muscle aches at the injection site and other sites on the body since an unknown date. At the time of this report, outcome of the events was unknown and their causality assessment was not reported by the physician. There was no product quality complaint. Additional information has been requested.
This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 016M20A) for COVID-19 vaccination. No Medical History information was reported. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The patient's last menstrual period was on 19-Jan-2021 and the estimated date of delivery was 24-Oct-2021. On 19-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy. On 18-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved. Not Provided. The patient believed she was pregnant four or five days before the date of her last menstrual cycle. Concomitant medication and treatment information were not reported.
Adverse reactions: right arm deltoid muscle is red, swollen, warm to touch with knots to muscle. Instructed guardian to apply warm compresses and take ibuprofen q 6 hrs. Call pediatrician if further treatment needed.
Injection site discomfort; This case was reported by a nurse and described the occurrence of injection site discomfort in a 64-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 28th August 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced injection site discomfort. On an unknown date, the outcome of the injection site discomfort was recovered/resolved.   It was unknown if the reporter considered the injection site discomfort to be related to Shingrix.  Additional details were provided as follows: The reporter consent to follow up. For tolerance to 2nd dose, refer case US2019AMR199268. The case has been linked with the cases US2019AMR199256 and US2019AMR199259, reported by same reporter.
pt and mom returned 1/13/20 for office visit stating has had left arm pain since vaccination 12/31/19. pain mostly just at night while sleeping. hurts more if puts left arm over chest. PT ordered. if PT doesn't help then will do Neuro referral.
extremely soar right arm; weak all over body; body aches; significant headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 41 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 21Apr2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: VITAMIN D NOS; VIT C. Vaccination history included: Bnt162b2 (Sore arm, 12 hours first dose), when the patient was 41 years old, for COVID-19 immunisation, reaction(s): "Sore arm". The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 21Apr2021, outcome "recovered" (2021), described as "extremely soar right arm"; ASTHENIA (non-serious) with onset 21Apr2021, outcome "recovered" (2021), described as "weak all over body"; PAIN (non-serious) with onset 21Apr2021, outcome "recovered" (2021), described as "body aches"; HEADACHE (non-serious) with onset 21Apr2021, outcome "recovered" (2021), described as "significant headache". Therapeutic measures were not taken as a result of pain in extremity, asthenia, pain, headache.  Additional information: . The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Patient had no known allergies.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
POTENTIALLY EXPIRED VACCINE ADMINISTERED (VIAL WAS OPENED ON 06-OCT-2021 AT 9 AM AND VACCINE ADMINISTERED ON 07-OCT-2021 AT AROUND 12:30 TO 1 PM); This spontaneous report received from a pharmacist concerned a 19 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 211A21A expiry: 14-DEC-2021) dose was not reported, administered on 07-OCT-2021 for prophylactic vaccination. No concomitant medications were reported.  On 07-OCT-2021, the patient experienced potentially expired vaccine administered (vial was opened on 06-oct-2021 at 9 am and vaccine administered on 07-oct-2021 at around 12:30 to 1 pm). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of potentially expired vaccine administered (vial was opened on 06-oct-2021 at 9 am and vaccine administered on 07-oct-2021 at around 12:30 to 1 pm) was not reported. This report was non-serious.
States 2 hours after receiving FLUMIST, live vaccine. she developed a 10 mm lesion on her upper (L) lip. Took BENADRYL last night, which had no effect on the lesion. Will follow up with PCP if doesn't improve.
pt recv vax & w/in 6hr p/vax pt exp pain @ inj site;sx resolved in 1wk;2wk post vax pt began to exp intermittent muscle twitching;no tx was given;sx resolved by 2nd Engerix-B given;
Information has been received from a nurse practitioner concerning a patient who was vaccinated with a dose of varicella virus vaccine live. On approximately 15-May-2003. "approximately 2 weeks ago", the patient developed a mild case of chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No additional information was provided at this time. Additional information has been requested.
I have developed bilateral Tinnitus accompanied by occasional headaches. The ringing has not stopped since it began approx 10 days after the first doese.
pain; headache; shiver; a fever which is currently 99.7 F; This is a spontaneous report received from a non-contactable consumer (patient's husband). A female patient of an unspecified age (reported as 62, unit not reported) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date: unknown), via an unspecified route of administration, on 14Jan2021 10:00, at single dose, for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that the patient received the vaccine yesterday (14Jan2021) around 10:00 and around 20:00, the patient experienced pain, headache, shiver and a fever which is currently 99.7 F. The reporter asked if the patient can use antipyretics before or after vaccination with the BNT162B2 vaccine. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Today is 4/27, I have had a headache since the day after my 4th booster (4/8/22).  I had headaches after the last 3, but they went away. This one just won't quit. Not debilitating, but distracting and always there.
pt recvd vax; began screaming 1 1/2 hrs after vax;no apparent relief from apap w/ codeine;seen by MD;mom said pt crying from 12:30 & cont to cry till 3:25;
Initial spontaneous report received from a health care professional on 27 May 2010. A 49-year-old female patient with a history of Hashimoto's Disease received a left deltoid injection of TYPHIM VI (lot number D0191-2) on 28 April 2010. The patient had previously received oral TYPHOID, and was taking SYNTHROID concomitantly. She had no known allergies, and was not ill at the time of vaccination. On 01 May 2010, 3 days post-vaccination, the patient complained of weakness in the left leg and left shoulder. Symptoms became progressively worse, and at the time of the report the patient was experiencing numbness in her left leg. She also complained of swollen lymph nodes, and noted that she had seen 4 doctors. Symptoms remained ongoing at the time of the report. Documents held by sender: None.
Information has been received from a physician concerning a female patient who on 03-NOV-2008 was vaccinated with a 0.5 ml dose of VARIVAX (Oka/Merck).  The physician reported that on 14-NOV-2008 the patient developed a rash on her truck after vaccination.  The patient sought unspecified medical attention.  Additional information has been requested.
This case was reported by a consumer and described the occurrence of erythema in a 58-year-old male subject who was vaccinated with Flu vaccine (GlaxoSmithKline). A physician or other health care professional has not verified this report. Concurrent medications included LIPITOR, TOPROL, Lisinopril, Aspirin, Metformin, Glimepiride, Gingko biloba and Saw palmetto. On 27 September 2010 at 18:00 the subject received 1st dose of Flu vaccine in the left arm. On 29 September 2010, 2 days after vaccination with Flu vaccine, the subject experienced erythema, swelling and hot to touch. At the time of reporting the events were worse. Attribution of the events to flu vaccine was unknown by the reporter.
5/23-5/24, nose pain, swallow inside and under nose,  fever, joint pain, muscle sore and headache 5/25-5/31, nose pain, infection area developing, fever, headache visited urgent care on 5/28, prescribed cephalexin (keflex) and mupirocin.
Client was administered the second dose of the varicella vaccine at 3months after the first dose. However, there were only 21 days apart from the 2nd dose of MMR vaccine received on 10/12/22.
severe pains in his legs from the thigh down to the toes; This is a spontaneous report from a contactable consumer (patient).  A 78-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number EL9262, expiration date not reported), via an unspecified route of administration from 22Jan2021 to 22Jan2021 at a single dose for Covid-19 immunization.  Medical history included 2 knee operations.  The patient's concomitant medications were not reported.  The patient received the first vaccine on Friday, 22Jan2021. He was fine on Friday and had sent reports with a text notification. On 23Jan2021, Saturday night, he was woken up by severe pains in his legs from the thigh down to the toes. He took an acetaminophen (TYLENOL) about 20 minutes after the pain and about 30-45 minutes the pain went away. The next day, he was fine during the day, but the same thing occurred to him at night, and he took another acetaminophen and it went away. He had 2 knee operations with new knees and thought it was something to do with that. Outcome of the events was unknown.
Feeling crumby; Not feeling well; Body aches; Fever over 102°F/temperature of 102 and 103 the temperature spikes up; Muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Feeling crumby), MALAISE (Not feeling well), PAIN (Body aches), PYREXIA (Fever over 102°F/temperature of 102 and 103 the temperature spikes up) and MYALGIA (Muscle aches) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 025A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced MALAISE (Feeling crumby), MALAISE (Not feeling well), PAIN (Body aches), PYREXIA (Fever over 102°F/temperature of 102 and 103 the temperature spikes up) and MYALGIA (Muscle aches). The patient was treated with ACETAMINOPHEN (oral) at an unspecified dose and frequency. At the time of the report, MALAISE (Feeling crumby), MALAISE (Not feeling well), PAIN (Body aches), PYREXIA (Fever over 102°F/temperature of 102 and 103 the temperature spikes up) and MYALGIA (Muscle aches) had not resolved.            Concomitant product use was not reported.  Treatment medication included acetaminophen.  Follow-up information received 08-Apr-2021 included added event of fever.  The patient received both scheduled doses of mRNA-1273 prior to the event(s); therefore, action taken with the drug in response to the event(s) is not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 08-Apr-2021: No specific follow-up information recorded.
Pt vaccinated with Yellow fever/Meningococcal developed diffuse urticaria treated with Benadryl.
Started to run a low grade fever around 20:00 thus having to leave work 30 minutes early. By 2130 that evening was in the kitchen to get a snack and collapsed to the ground instead of passing out as I knew that if I did not let myself go to the ground I would have passed out. Was unable to sleep most of the night due to pain by early morning 06:00 I had a low-grade fever of 100.3. Extreme joint and muscle aches throughout entire body. My right arm where I received the vaccine was in so much pain was not able to use it also found a lump about the size of a large acorn on my collarbone more to the medial side that was firm and extremely sensitive to touch. Majority of the pain has been to the upper right arm going??
Information has been received from a consumer referring to a female consumer. The patient's medical history and concurrent conditions were not provided. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (dose, route and lot number not provided). On an unknown date, she had gotten two outbreaks of shingles after receiving the "Shingles vaccine" as well. The outcome of shingles was unknown. This is one of several reports received from the same source. Additional information has been requested.
This spontaneous report was received from a pharmacist refers to an approximately 65 year old female patient. On an unknown date approximately in September 2012, the patient was vaccinated with lot # (669579/0595AA), 0.5 ml PNEUMOVAX23 which expired on 30-AUG-2012. No concomitant medications were reported. No adverse event were reported. Additional information has been requested.
just a little tired; didn't feel good; I was in bed for a couple days; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (005570). The reporter is the patient.  An 80-year-old patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1; manufacturer unknown), for Covid-19 vaccination; Covid-19 vaccine (Dose 2; manufacturer unknown), for Covid-19 vaccination. The following information was reported: FATIGUE (non-serious), outcome "recovered", described as "just a little tired"; FEELING ABNORMAL (non-serious), outcome "recovered", described as "didn't feel good"; BEDRIDDEN (non-serious), outcome "recovered", described as "I was in bed for a couple days".  Additional information included Patient called trying to reach Drug safety unit because received two surveys one was for Premarin and another one was for Pantoprazole. Patient explained "I got the Pfizer booster shot the second one not the first one the second one and like a day and a half later I broke out in a sweat and I passed out and that's how I broke my ankle. So I don't know why I got it for these other two things cause like I said I use to take Protonix and Protonix was perfect and I cant afford it now so I have to take something else and Premarin I've been taking since I've been in my 40's" Patient also stated "The first booster that I got it I was just a little tired and I didn't feel good and I was in bed for a couple days but this one reacted different. That's all I can tell you. So I have nothing to feel out because I am okay now. Note: The form of the Premarin was not provided on the phone call but retrieved from the system  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Mid April became short of breath, had paid in legs while walking, very tired.   After several tests scheduled for heart cath 6/22/21. Cleared 2 blockages on right side of heart and placed 2 stents.   On 6/23/21 had second heart cath to clear blockages on left side of heart and placed one stent.  Still has blockage in right groin they are watching and may need procedure to clear that if worsens.
On 11/24/98, this pt recieved vax. Subsequent to receiving one dose of varicella virus vax, in 08/99, the pt experienced clinical varicella with more than 50 papulovesicular lesions with oozing. The eruptions lasted 2 weeks, cleared then reappeared.  The pt was afebrile. The pt sought unspecified medical treatment. Additionally the pharmacist reported that his other child experienced a similar reaction. Follow up information received from the physician indicated that on 08/11/1999 the pt experienced atypical varicella. The pt's sibling experienced the same reaction on 07/28/1999. On an unspecified date the pt recovered. No further information is available.
lump on my left hand; hurts; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a sponsored program (005570). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MASS (non-serious), outcome "unknown", described as "lump on my left hand"; PAIN (non-serious), outcome "unknown", described as "hurts".  Additional information: It was reported that, on 26th (unspecified date) patient took the vaccination, the Pfizer COVID vaccine. Reports that was the first one and today (at the time of report) patient see a lump on left hand. It's like not exactly the place where patient got the shot but it's little lower to that place and when patient put some pressure or rub that lump, the lump hurts.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a lawyer regarding a case in litigation concerning a female who on 03-MAY-1998 was vaccinated with a second dose of Recombivax HB vaccine (yeast). Within hours, she developed a rash on her abdomen. Several days later, her ailments increased to include stiff and painful joints. The patient's condition was described as rheumatoid arthritis. It was reported that the patient "continues to suffer from this permanent condition (disabling), taking daily medication to keep the pain, swelling and stiffness under control". It was reported that the patient's physician decided that she should not receive the third dose of Recombivax HB vaccine (yeast). The doctors attributed her rheumatoid arthritis to her vaccination with Recombivax HB vaccine (yeast). Additional information is not expected.
Intense, persistent pressure headache across the forehead throughout the day, tension down back neck and shoulders sometimes accompanied by dizziness.  Lasted thru 3 weeks after first dose and 2nd week after second dose.  Currently still experiencing slight pressure across forehead (2nd week after second dose).  Went to urgent care 3 days after the second dose was administered due to dizziness that accompanied pressure headaches.  Followed up with doctor office visit 10 days after the second dose was administered.
Systemic: Vomiting-Mild, Additional Details: He vomited on the floor for about 5 minutes after receiving the vaccination, but stopped vomiting after 2 or 3 times. He had no fever but a little bit of sweating. He said it felt like food was stuck in his throat and refused to drink water and call the ambulance. He trowed up chicken chunks.  He waited in the post vaccination care area for another 20 minutes and felt better so he left.
pain in arm that shoots to the neck followed by an episode of extreme exhaustion  started on saturday - still experiencing on wednesday
pt recvd vax; had fever 102 the day before vax; pt became lethargic & pale the day p/ recving vax;
Initial report was received on 21 May 2013 from a consumer who is also the patient. A male patient had received in July or August 2007 MENACTRA (lot number, route and site of administration not reported) and ADACEL (lot number, route and site of administration not reported) and "soon after" developed swollen tonsils. Two months after vaccination the patient had mononucleosis and developed chronic migraine headaches, nerve pain, tingling and numbness of hands and feet, organ pain, experiences shortness of breath, memory loss, unrestful sleep, decreased energy and sensitivity to light and sound. According to the reporter, he had "GBS like symptoms". The patient had no known allergies and no history of medical conditions. The patient is being seen by a physician. No further information was provided at the time of the report. The patient's outcome was not recovered. Documents held by sender: none.
Fever, loss of energy, chills, general weakness and feel of illness, body aches and extreme redness at site injection.  A red ring surrounding injection site is visible.
Patient stated that her arm was swollen, red, hard to touch, and painful after the Tdap and ZOSTAVAX injection.
Persistent hiccups started 1 hour -1.5 hrs after vaccine. Lasted for 3 days straight. MD prescribed baclofen and it worked immediately.
it was rpt pt son vax 6/5/98 & on approx 6/19 pt devel typical varicella disease. 6/22 she presented w/more than 50 lesions all over her body MD wasn't sure if from son's vax or wild type varicella. MD believed it was wild varicella virus